SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 7.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $29,000 | -71.3% | 24,772 | -20.3% | 0.00% | – |
| Q4 2021 | $101,000 | -27.3% | 31,093 | 0.0% | 0.00% | – |
| Q3 2021 | $139,000 | -67.9% | 31,093 | -60.9% | 0.00% | -100.0% |
| Q2 2021 | $433,000 | -18.6% | 79,478 | +11.7% | 0.00% | 0.0% |
| Q1 2021 | $532,000 | -22.0% | 71,175 | +13.2% | 0.00% | 0.0% |
| Q4 2020 | $682,000 | +22.7% | 62,862 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $556,000 | -16.6% | 62,862 | +0.4% | 0.00% | 0.0% |
| Q2 2020 | $667,000 | +113.8% | 62,595 | +18.9% | 0.00% | 0.0% |
| Q1 2020 | $312,000 | -16.4% | 52,667 | -2.5% | 0.00% | 0.0% |
| Q4 2019 | $373,000 | -32.7% | 54,023 | +1.3% | 0.00% | 0.0% |
| Q3 2019 | $554,000 | +12.1% | 53,352 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $494,000 | +35.0% | 53,352 | +33.3% | 0.00% | 0.0% |
| Q1 2019 | $366,000 | +64.1% | 40,014 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $223,000 | -51.6% | 40,014 | +3.4% | 0.00% | 0.0% |
| Q3 2018 | $461,000 | +20.4% | 38,714 | +3.3% | 0.00% | 0.0% |
| Q2 2018 | $383,000 | +25.2% | 37,477 | +59.2% | 0.00% | 0.0% |
| Q1 2018 | $306,000 | +59.4% | 23,546 | +19.5% | 0.00% | – |
| Q4 2017 | $192,000 | -33.8% | 19,700 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $290,000 | -18.8% | 19,700 | -11.3% | 0.00% | 0.0% |
| Q2 2017 | $357,000 | +133.3% | 22,200 | +131.2% | 0.00% | – |
| Q1 2017 | $153,000 | +30.8% | 9,600 | 0.0% | 0.00% | – |
| Q4 2016 | $117,000 | -14.6% | 9,600 | -3.0% | 0.00% | – |
| Q3 2016 | $137,000 | – | 9,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |